Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 16 Jun 2026

Case Report: Long-term maternal and neonatal outcomes after nivolumab therapy in metastatic tonsillar sarcomatoid squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Elisabetta Guida
Benedetta Apollonio
Chiara Bungaro
Fabio Mele
Sabino Strippoli
Michele Guida

Frontiers in Immunology

doi 10.3389/fimmu.2026.1826390

166 views

Case Report

Published on 16 Jun 2026

Case Report: The “atoll sign”: a case series on an unusual radiological pattern of immune-mediated pneumonitis

in Cancer Immunity and Immunotherapy

Samuele Compagno
Alessandro Di Federico
Andrea De Giglio
Filippo Natali
Tommaso Abbate
Federica Ciccarese
Francesca Giunchi
Mattia Riefolo
Giorgia Dalpiaz
Stefania Damiani

Frontiers in Immunology

doi 10.3389/fimmu.2026.1791312

200 views

Original Research

Published on 16 Jun 2026

Efficacy of PD-1/PD-L1 and LAG-3 immune checkpoint inhibitors in the treatment of patients with solid tumor

in Cancer Immunity and Immunotherapy

Dahai Hu
Junyi Duan
Piao Xie
Jixing Li
Luyu Zhao
Bin Chen
Rongzhao Lu
Hui Tang
Xiaofei Zheng
Liangzhuo Qu

Frontiers in Immunology

doi 10.3389/fimmu.2026.1809975

167 views

Original Research

Published on 16 Jun 2026

The CSF1+ tumor cell–SPP1+ macrophage axis drives gastric cancer progression and immunotherapy resistance

in Cancer Immunity and Immunotherapy

Heng Zhang
Yundong You
Jinhao Peng
Qinhao Du
Xifan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2026.1817573

254 views

Original Research

Published on 16 Jun 2026

TMEM160 promotes hepatocellular carcinoma cell proliferation, invasion, and immune evasion by regulating the VEGFA/PI3K/AKT signaling axis

in Cancer Immunity and Immunotherapy

Guodong Shi
Dehua Liu
Jinhan Qiao

Frontiers in Immunology

doi 10.3389/fimmu.2026.1829095

192 views

Original Research

Published on 16 Jun 2026

Programmed cell death ligand 1 in correlation with BRAFV600E mutation, molecular characteristics and biological behavior in ameloblastoma

in Cancer Immunity and Immunotherapy

Aijing Pan
Zhipeng Xie
Jianhui Zhan
Yifeng Zhao
Yue Du
Kai Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1762600

207 views

Original Research

Published on 16 Jun 2026

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation

in Cancer Immunity and Immunotherapy

Lin Ran
Zhaoan Lian
Yong Tian
Li Qin
Yingchun Xiang
Xiaohao Yan
Chengyu Shui

Frontiers in Immunology

doi 10.3389/fimmu.2026.1850891

345 views

Original Research

Published on 16 Jun 2026

Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study

in Cancer Immunity and Immunotherapy

Cheng Wang
Shuaipeng He
Dan Li
Biao Zhang
Yu Dai
Can Li
Xuan Li
Le Kang
Shujun Yang
Su Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1809094

174 views

Review

Published on 16 Jun 2026

Exosomal microRNAs in colorectal cancer communication networks: implications for metastasis, therapy resistance, and precision medicine

in Cancer Immunity and Immunotherapy

Ashutosh Kumar Maurya
Sheefa Mirza

Frontiers in Immunology

doi 10.3389/fimmu.2026.1872130

206 views

Review

Published on 16 Jun 2026

Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective

in Cancer Immunity and Immunotherapy

Dong Wu
Qing Yu
Qixiang Wu
Xiaoying Wang
Haojie Wei
Fengli Li
Guangli Li
Xiaowu Wang
Xiaojuan Wang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1854718

327 views

Original Research

Published on 16 Jun 2026

HK2 knockdown is associated with context-dependent inflammatory and angiogenesis-related transcriptional programmes in glioblastoma cells

in Cancer Immunity and Immunotherapy

Christopher Edwards
Taylor Richards
Hafid Omar Al-Hassi
Surya Prakash Shivakumar
Benjamin Small
Kate Butcher
Tracy Warr
Mark Morris
Timothy Dawson
Michael D. Jenkinson

Frontiers in Immunology

doi 10.3389/fimmu.2026.1842240

236 views

Review

Accepted on 15 Jun 2026

RhoA at the intersection of inflammation-driven and sporadic Colorectal Cancer

in Cancer Immunity and Immunotherapy

Sofia Elena Muccioli
Laura Hidalgo-García
Phuong Ngo
Markus F. Neurath
Rocío López Posadas

Frontiers in Immunology

Original Research

Accepted on 15 Jun 2026

Mechanism of Liposome Arsenic Trioxide Regulating Tumor Microenvironment and Sensitizing Tumor Immune Response After Radiofrequency Ablation

in Cancer Immunity and Immunotherapy

Chao Liang
Shuguang Ju
Hao Li
Daqian Han
Jiacheng Wang
Yangyang Niu
Jianzhuang Ren
Xinwei Han
Xuhua Duan

Frontiers in Immunology

Original Research

Accepted on 15 Jun 2026

Efficacy and Safety of First-Line Chemoimmunotherapy Versus Chemotherapy Alone for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma: A Systematic Review and Real-World Cohort Study

in Cancer Immunity and Immunotherapy

Feng Chen
Yan SU
Xiandong Zeng
Ming Jiang
Yu Huang
Liuye Pan
Linlin Xiao
Yirao Qin
Xiangyuan CEN
Jing Bai

Frontiers in Immunology

Review

Accepted on 15 Jun 2026

Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment

in Cancer Immunity and Immunotherapy

Yunwei Su
Yan Dong

Frontiers in Immunology

Case Report

Accepted on 15 Jun 2026

Clinical Complete Response to Serplulimab Plus Bevacizumab and Chemotherapy in MSS/KRAS-Mutant Metastatic Sigmoid Colon Adenocarcinoma: A Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Qiao Luo
Haiyan Zhang
滨茹狄
Yaowen Liu
Yulin Lei
Haixia Liu
Jianmei Wang
Luo Yuhao

Frontiers in Immunology

Original Research

Accepted on 15 Jun 2026

Combinatorial therapy with resveratrol sensitizes glioblastoma to NKG2D CAR-T cells

in Cancer Immunity and Immunotherapy

Xiaochun Wan
Wei Liang
YE XIAO TANG
Muhammad Auwal Saliu
Mansur Dabai Salisu
Zhiming Xu
SHU XU
Maoxuan Liu

Frontiers in Immunology

Original Research

Accepted on 15 Jun 2026

Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels

in Cancer Immunity and Immunotherapy

Fabia De Oliveira Andrade
Kerrie Briggs Bouker
Melike Ozgul-Onal
Lu Jin
Idalia Cruz
William Helferich
Audrey Gao
Karla Andrade de Oliveira
Vivek Verma
Christopher Staley

Frontiers in Immunology

Case Report

Accepted on 15 Jun 2026

Long-Term Disease Control with Immunotherapy in Primary Mandibular Adenoid Cystic Carcinoma Presenting with Pulmonary Metastasis: A Case Report

in Cancer Immunity and Immunotherapy

Hongcheng Yang
Yanzhen Lai
Qingqing li
Haijin yang
Meichen ji
Luo Xuqiang
Xie zhu
Yun Li
Huiyu Wu
Peixin Tan

Frontiers in Immunology

Review

Accepted on 15 Jun 2026

Navigating the Gut–Metabolite–Immune Axis: Enhancing Efficacy and Mitigating Toxicity of Immune Checkpoint Inhibitors

in Cancer Immunity and Immunotherapy

Yu Zhang
Shengnan Wang
Shuang Chang
Yuanyuan Li
Yexing Dang
Zhihao Wang

Frontiers in Immunology

Case Report

Accepted on 15 Jun 2026

Localized Neutrophilic Dermatosis at a Split-Skin Donor Site during PD-1 Blockade: A Unique Immune-Related Adverse Event

in Cancer Immunity and Immunotherapy

Veselina Moravenova
Raphael Wilhelm
Jakob Veeser
Klajdi Begaj
Beate Weidenthaler-Barth
Stephan Grabbe
Henner Stege
Miriam Wittmann

Frontiers in Immunology

Case Report

Accepted on 15 Jun 2026

Non-bacterial Cystitis Following Treatment with Toripalimab for Alpha-fetoprotein-producing Gastric Adenocarcinoma:a case report

in Cancer Immunity and Immunotherapy

Zhenpeng Li
Xiuxiu Yi
Jie Fu
Yan Liang
Sensen Zhang
Xv Yang
Zhonghai Du

Frontiers in Immunology

Original Research

Accepted on 15 Jun 2026

MCT4 Drives HCC Progression by Activating MMPs and Polarizing M2 Macrophages

in Cancer Immunity and Immunotherapy

Kaiyuan Zhang
Xiaochen Ni
楚航王
Jianing Guo
Wei Fan
Tao Sun
Tao Jiang
Guangji Zhang

Frontiers in Immunology

Review

Accepted on 15 Jun 2026

B7-H3 (CD276): An Actionable Therapeutic Target and Prognostic Biomarker across Human Malignancies

in Cancer Immunity and Immunotherapy

Dayna Smith
Anudishi Tyagi
Venkata Lokesh Battula

Frontiers in Immunology

10,534 articles

articles

Case Report: Long-term maternal and neonatal outcomes after nivolumab therapy in metastatic tonsillar sarcomatoid squamous cell carcinoma

Case Report: The “atoll sign”: a case series on an unusual radiological pattern of immune-mediated pneumonitis

Efficacy of PD-1/PD-L1 and LAG-3 immune checkpoint inhibitors in the treatment of patients with solid tumor

The CSF1+ tumor cell–SPP1+ macrophage axis drives gastric cancer progression and immunotherapy resistance

TMEM160 promotes hepatocellular carcinoma cell proliferation, invasion, and immune evasion by regulating the VEGFA/PI3K/AKT signaling axis

Programmed cell death ligand 1 in correlation with BRAFV600E mutation, molecular characteristics and biological behavior in ameloblastoma

Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation

Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study

Exosomal microRNAs in colorectal cancer communication networks: implications for metastasis, therapy resistance, and precision medicine

Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective

HK2 knockdown is associated with context-dependent inflammatory and angiogenesis-related transcriptional programmes in glioblastoma cells

RhoA at the intersection of inflammation-driven and sporadic Colorectal Cancer

Mechanism of Liposome Arsenic Trioxide Regulating Tumor Microenvironment and Sensitizing Tumor Immune Response After Radiofrequency Ablation

Efficacy and Safety of First-Line Chemoimmunotherapy Versus Chemotherapy Alone for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma: A Systematic Review and Real-World Cohort Study

Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment

Clinical Complete Response to Serplulimab Plus Bevacizumab and Chemotherapy in MSS/KRAS-Mutant Metastatic Sigmoid Colon Adenocarcinoma: A Case Report and Literature Review

Combinatorial therapy with resveratrol sensitizes glioblastoma to NKG2D CAR-T cells

Isoflavones impair anti-PD1 efficacy in breast cancer, regardless of dietary fiber or fecal short-chain fatty acid levels

Long-Term Disease Control with Immunotherapy in Primary Mandibular Adenoid Cystic Carcinoma Presenting with Pulmonary Metastasis: A Case Report

Navigating the Gut–Metabolite–Immune Axis: Enhancing Efficacy and Mitigating Toxicity of Immune Checkpoint Inhibitors

Localized Neutrophilic Dermatosis at a Split-Skin Donor Site during PD-1 Blockade: A Unique Immune-Related Adverse Event

Non-bacterial Cystitis Following Treatment with Toripalimab for Alpha-fetoprotein-producing Gastric Adenocarcinoma:a case report

MCT4 Drives HCC Progression by Activating MMPs and Polarizing M2 Macrophages

B7-H3 (CD276): An Actionable Therapeutic Target and Prognostic Biomarker across Human Malignancies